Synapse - American Society of Hematology

American Society of Hematology

SHERPA: Blue

People

Giralt
Zelenetz
Levine
Perales
Tallman
O'Reilly
Horwitz
Devlin
Palomba
Abdel-Wahab

Groups

Department of Medicine (4000)
Hematologic Malignancies, Division of (3803)
Center for Hematologic Malignancies (3680)
GSK Faculty (1590)
Adult Leukemia (1343)
Sloan Kettering Institute Faculty (1075)
Bone Marrow Transplant (988)
Center for Molecular Imaging and Biotechnology (CMIB) (955)
Lymphoma (941)
Tow Center for Developmental Oncology (TCDO) (882)

Search Within

Results (5555)

Export to EndNote / Excel

Preliminary results from a phase 1 dose escalation study of FHD-286, a novel BRG1/BRM (SMARCA4/SMARCA2) inhibitor, administered as an oral monotherapy in patients with advanced hematologic malignancies

Meeting Abstract

DiNardo, C. D.; Savona, M. R.; Kishtagari, A.; Fathi, A. T.; Bhalla, K. N.; Agresta, S.; Reilly, S.; Almon, C.; Hentemann, M.; Hickman, D.; more...
Blood (2023)

Fulltext@MSK | Save

An externally controlled trial to indirectly compare tazemetostat plus lenalidomide and rituximab versus lenalidomide and rituximab after at least one prior systemic therapy in patients with refractory and relapsed follicular lymphoma

Meeting Abstract

Nastoupil, L. J.; Salles, G.; Leonard, J. P.; Morschhauser, F.; Veazey, K. J.; Perrot, V.; Doban, V.; Bonnet, M.; Sosinsky, A. Z.; Crowley, A.; more...
Blood (2023)

Fulltext@MSK | Save

Trial in progress: Patient-reported outcome measures in the prospective observational cohort study of patients at risk for chronic graft-versus-host disease in the United States (THRIVE)

Meeting Abstract

Ponce, D. M.; El-Jawahri, A.; Hamilton, B. K.; Khera, N.; Bhatt, V.; Galvin, J.; Lee, C. J.
Blood (2023)

Fulltext@MSK | Save

Clinical practice gaps in managing patients with myelofibrosis: Comparison of healthcare professional and expert treatment choices provided to an online decision support tool

Meeting Abstract

Topping, R. P.; Bose, P.; Mascarenhas, J.; Rampal, R. K.; Stein, B. L.; Quill, T. A.; Mesa, R. A.
Blood (2023)

Fulltext@MSK | Save

EPCORE FL-1: Phase 3 trial of subcutaneous epcoritamab with rituximab and lenalidomide (R (2)) Vs R (2) alone in patients with relapsed or refractory follicular lymphoma

Meeting Abstract

Falchi, L.; Morschhauser, F.; Linton, K.; Huang, H.; Galderisi, F.; Quadri, S.; Zeng, L.; Hoehn, D.; Seymour, J. F.
Blood (2023)

Fulltext@MSK | Save

"Defining the optimal post-CART monitoring period in recipients of axicabtagene ciloleucel and tisagenlecleucel"

Meeting Abstract

Wesson, W.; Lutfi, F.; Porter, D. L.; Bachanova, V.; Nastoupil, L. J.; Riedell, P. A.; Perales, M. A.; Maziarz, R. T.; Brower, J.; Shah, G. L.; more...
Blood (2023)

Fulltext@MSK | Save

Whole-genome sequencing reveals distinct mutational signatures in multiple myeloma patients with African ancestry compared with those of non-African ancestry

Meeting Abstract

Maclachlan, K. H.; Blaney, P.; Cirrincione, A.; Chu, T. R.; Poos, A. M.; Brown, E. E.; Manasanch, E. E.; Hoering, A.; Hou, L. M.; Gagler, D.; more...
Blood (2023)

Fulltext@MSK | Save

A phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in patients with JAK inhibitor-naive myelofibrosis and moderate thrombocytopenia (XPORT-MF-044)